IMMUCELL CORP /DE/ Quarterly Current Income Tax Expense (Benefit) in USD from Q2 2020 to Q2 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Immucell Corp /De/ annual/quarterly Current Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q2 2023.
- Immucell Corp /De/ Current Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $1.53K, a 32.8% increase year-over-year.
- Immucell Corp /De/ Current Income Tax Expense (Benefit) for the twelve months ending June 30, 2023 was $8.43K, a 26.5% decline year-over-year.
- Immucell Corp /De/ annual Current Income Tax Expense (Benefit) for 2023 was $4.63K, a 39.7% decline from 2022.
- Immucell Corp /De/ annual Current Income Tax Expense (Benefit) for 2022 was $7.67K, a 16.3% decline from 2021.
- Immucell Corp /De/ annual Current Income Tax Expense (Benefit) for 2021 was $9.17K, a 104% increase from 2020.
Current Income Tax Expense (Benefit), Trailing 12 Months (USD)
Current Income Tax Expense (Benefit), Quarterly (USD)
Current Income Tax Expense (Benefit), YoY Quarterly Growth (%)